Images List Premium Download Classic

Neurological

Neurological-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Multi-component method of real-time collaboration for the purpose of creating and negotiating a common objective ...
January 18, 2018 - N°20180018409

A multi-component method of real-time collaboration for the purpose of creating and negotiating a common object plan by mitigating and overcoming the barriers created by negative neurological hormones while facilitating the release of positive hormones throughout each phase of the method.
NEW Substituted pyridazine carboxamide compounds
Xcovery Holding Company Llc
January 18, 2018 - N°20180016240

The new pyridazine derivatives have unexpected drug properties as inhibitors of protein kinases especially against alk and are useful in treating disorders related to abnormal protein kinase activities such as cancer, neurological and psychiatric diseases.
NEW Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
Angiochem Inc.
January 18, 2018 - N°20180015180

The present invention relates to short polypeptides (e. G., fewer than 19 amino acids in length) and longer polypeptides (e. G., 19 or more amino acids in length) having one or more d-amino acids as targeting moieties. These polypeptides, when conjugated to agents (e. G., therapeutic agents or transport vectors) are capable of transporting the agents across the bbb or into particular ...
NEW Neurological Patent Pack
Download 364+ patent application PDFs
Neurological Patent Applications
Download 364+ Neurological-related PDFs
For professional research & prior art discovery
inventor
  • 364+ full patent PDF documents of Neurological-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Inflatable bladder hand orthosis
Mediroyal Nordic Ab
January 18, 2018 - N°20180014959

An orthosis comprises a palmar splint section aligned with a palm of a hand of a human subject and a wrist and forearm splint section extending from the palmar splint section to a distance corresponding to at least a portion of a forearm of the human subject. A bladder support is pivotally connected to the palmar splint section and comprises ...
NEW Bone fusion system
University Of South Florida
January 18, 2018 - N°20180014866

A method and system for performing bone fusion and/or securing one or more bones, such as adjacent vertebra, are disclosed. The screws include a threaded tip connected to a main shaft and a threaded outer sleeve that rotates relative to the outer shaft until locked down. Independent rotation of the threaded outer sleeve relative to the threaded distal tip ...
Pharmacological modulators of gabaa receptors and their use
The Johns Hopkins University
January 11, 2018 - N°20180009859

The present invention provides polypeptides and their variants and derivatives which modulate gabaa receptor function at nanomolar quantities by binding to the α+/β− subunit interface, as well as methods of making and using the same. The inventive peptides are useful for the study of neurological disease and function and can have therapeutic applications.
Neurological Patent Pack
Download 364+ patent application PDFs
Neurological Patent Applications
Download 364+ Neurological-related PDFs
For professional research & prior art discovery
inventor
  • 364+ full patent PDF documents of Neurological-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive ...
Neurodyn Life Sciences Inc.
January 11, 2018 - N°20180008613

A method for the treatment of a neurodegenerative, psychiatric or neurological disease associated with a cholinergic deficit comprising administering gln-1062 or a pharmaceutically acceptable salt thereof by nasal administration to a patient in need thereof.
Transdermal delivery system containing galantamine or salts thereof
Taho Pharmaceuticals Ltd.
January 11, 2018 - N°20180008612

Disclosed herein is a transdermal delivery system comprising galantamine or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of galantamine to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as alzheimer's disease. Kits including the transdermal delivery system and methods of making such ...
Embolic coils and related components, systems, and methods
Boston Scientific Scimed, Inc.
January 11, 2018 - N°20180008273

The present invention relates generally to systems and methods for delivering embolic devices into a body lumen of a patient. These embolic devices are applicable to a variety of neurological and/or peripheral applications. In particular, the embolic devices may be used to occlude a vessel within a patient, and/or to treat aneurysms, arteriovenous malformations, traumatic fistulas, uterine fibroids ...
N-acetyl glucosamine as a biomarker of ms disease course
Mt. Sinai Hospital
January 04, 2018 - N°20180003717

The invention provides the art with a powerful diagnostic method of distinguishing relapse-remitting ms subjects from progressive ms subjects, based on the measurement of serum concentrations of n-acetylglucosamine (glcnac,), for the first time enabling rapid diagnosis of the progressive form of ms. Glcnac serum concentration can also be used to assess neurodegenerative status and ms progression in subjects suffering from ...
Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium
The United States Of America As Represented By The Department Of Veterans Affairs
January 04, 2018 - N°20180002741

The invention includes a method of diagnosis and treating autism associated with an overgrowth of beta2-toxin-gene-positive clostridium perfringens in the gut of an autistic subject. In one embodiment, the method comprises administering to the subject (e. G. A subject having an overgrowth of beta2-toxin-gene-positive clostridium perfringens in the gut) one or more agents to reduce or eliminate beta2...
Methods of treatment
Murray Goulburn Co-operative Co., Limited
January 04, 2018 - N°20180000908

The invention provides a method of treating a disorder characterised by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method ...
Method of treating neurological conditions with oleandrin
Phoenix Biotechnology, Inc.
January 04, 2018 - N°20180000852

A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside, and optionally triterpene(s), to a subject. The cardiac glycoside can be present in a dosage form.
Neurological Patent Pack
Download 364+ patent application PDFs
Neurological Patent Applications
Download 364+ Neurological-related PDFs
For professional research & prior art discovery
inventor
  • 364+ full patent PDF documents of Neurological-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
The Johns Hopkins University
December 28, 2017 - N°20170370943

The present invention relates to the field of biomarkers. More specifically, the present invention relates to biomarkers useful in diagnosing brain injury or neurodegeneration. In one embodiment, a method for diagnosing brain injury in a patient comprises the steps of (a) obtaining a sample from the patient; (b) determining the ratio of citrullinated to unmodified arginine residues at one or ...
Positive allosteric modulators of the muscarinic acetylcholine receptor m4
Vanderbilt University
December 28, 2017 - N°20170369505

Disclosed herein are tricyclic compounds, including pyrimido[4′,5′:4,5]thieno[2,3-c]pyridazine-8-amine, pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine-4-amine, pyrazino[2′,3′:4,5]thieno[3,2-d]pyrimidin-4-amine, pyrido[3′,2′:4,5]furo[3, 2-d]pyrimidin-4-amine, and pyrimido[4′,5′:4,5]furo[2,3-c]pyridazin-8-amine compounds, which may be useful as positive allosteric modulators of the muscarinic acetylcholine receptor m4 (machr m4). Also ...
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
Deuterx, Llc
December 28, 2017 - N°20170369420

The invention provides enantiopure deuterium-enriched bupropion, pharmaceutical compositions, and methods of treating neurological disorders, movement disorders, cardiovascular disorders, metabolic disorders, and other disorders using enantiopure deuterium-enriched bupropion. A preferred aspect of the invention provides methods of treating obesity and sexual dysfunction using enantiopure deuterium-enriched bupropion.
New stimulation design for neuromodulation
December 28, 2017 - N°20170368339

The present application relates to a new stimulation design which can be utilized to treat neurological conditions. The stimulation system produces a burst mode stimulation which alters the neuronal activity of the predetermined site, thereby treating the neurological condition or disorder. The burst stimulus comprises a plurality of groups of spike pulses having a maximum inter-spike interval of 100 milliseconds. The ...
Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2)
Siemens Healthcare Diagnostics Inc.
December 28, 2017 - N°20170368171

The invention provides human adipor2 which is associated with the cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, respiratory diseases, inflammation, neurological diseases, urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, respiratory diseases, inflammation, neurological diseases, urological diseases. The ...
Composition containing poria cocos bark extract for preventing, improving or treating neurodegenerative disorders
Dong-a St Co., Ltd.
December 28, 2017 - N°20170368122

The present invention relates to a pharmaceutical composition and a food composition for preventing or ameliorating degenerative neurological disease comprising poria cocos peel extract for preventing, or treating neurodegenerative disorders. Poria cocos peel extract which is the active ingredients contained in the composition of the present invention, has a memory ameliorating activity through inhibiting of acetylcholine esterase and a neuroprotective ...
Cells expressing parathyroid hormone 1 receptor and uses thereof
Tithon Biotech Inc.
December 28, 2017 - N°20170368107

Disclosed herein are pluripotent stem cells cultured with one or more peptide and methods of isolating said stem cells. Also disclosed are methods of targeting the stem cells to a desired region or area within an organism. Also disclosed are methods of using the isolated stem cells for the improvement of fertility, for the promotion of hair growth, for the ...
Composition including stem cell-derived microvesicles for promoting neurogenesis
Samsung Life Public Welfare Foundation
December 28, 2017 - N°20170368103

The present invention relates to a composition including stem cell-derived microvesicles as an active ingredient for promoting neurogenesis. The stem cell-derived microvesicles according to the present invention can promote neurogenesis and migration of nerves and also promote angiogenesis in vascular endothelial cells, and thus can be usefully used in treatment of neurological damage.
Loading